Interestingly, recent studies highlight how the cleavage and nuclear accumulation of TβRI are selectively involved in TGF-β pathway activation in tumors, including prostate, breast and lung carcinomas, suggesting that there is another non-Smad mechanism that is activated by TGF-β cytokines. This evidence concerns the gene TGFB1 and lung carcinoma.